NGVT 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• During 2026, dispositions within our former Performance Chemicals reportable segment resulted in a change to the segment's name. Historically, our Performance Chemicals reportable segment consisted of the Pavement Technologies, industrial specialties, and road markings product lines. Following the s…

• Long-Lived Asset Impairment Charge - Advanced Polymer Technologies Asset Group

• We periodically evaluate whether current events or circumstances indicate that the carrying value of our long-lived assets, including intangible assets, to be held and used may not be recoverable. If such circumstances are determined to exist, an estimate of undiscounted future cash flows produced b…

• As the sale process for the Advanced Polymer Technologies segment progressed during the second quarter of 2026, information obtained from potential buyers indicated that its carrying amount may not be recoverable. Accordingly, we determined that a triggering event had occurred and performed a recove…

• Based on the results of the quantitative analysis, which was based on both quoted market prices in active markets and a discounted value of estimated future cash flows, we concluded that the carrying value of the Advanced Polymer Technologies asset group exceeded its fair value. As a result, we reco…

相对上期删除的文字 · 来源:10-Q · 2026-05-07

• On July 19, 2018, we filed suit against BASF Corporation ("BASF") in the United States District Court for the District of Delaware (the "Delaware Proceeding") alleging BASF infringed Ingevity's patent covering canister systems used in the control of automotive gasoline vapor emissions (U.S. Patent N…

• On September 15, 2021, a jury in the Delaware Proceeding issued a verdict in favor of BASF on the BASF Counterclaims and awarded BASF damages of approximately $28.3 million, which trebled under U.S. antitrust law to approximately $85.0 million. On May 18, 2023, the court in the Delaware Proceeding e…

• On March 13, 2024, we appealed the verdict as well as the U.S. District Court's November 2020 dismissal of our patent infringement claims against BASF to the U.S. Federal Circuit Court of Appeals. On February 11, 2026, the U.S. Federal Circuit Court of Appeals ruled against Ingevity on our appeal an…

• The full amount of the settlement of $113.2 million is accrued in "Accrued expenses" on the condensed consolidated balance sheet as of March 31, 2026 and the $16.2 million charge taken during the quarter was included within "Other (income) expense, net" on the condensed consolidated statements of op…

• On April 15, 2026, we completed the sale of our road markings product line to PPG Industries Inc. for $65 million, subject to customary adjustments for working capital, indebtedness and transaction expenses (the "Disposition").

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• On May 13, 2026, David H. Li, President and Chief Executive Officer of Ingevity Corporation, adopted a Rule 10b5-1 trading arrangement. The arrangement provides for the sale of up to 20,092 shares of Ingevity common stock and is scheduled to expire on May 13, 2027, subject to earlier termination in …

• On June 22, 2026, the company granted restricted stock units with respect to 2,063 shares of its Common Stock to Ryan Cotterman under the company’s 2025 Omnibus Incentive Plan, as amended (the “Plan” and such grant, the “RSU Grant”). It was recently determined that the RSU Grant may be void or voida…

相对上期删除的文字 · 来源:10-Q · 2026-05-07

• None of our directors or executive officers adopted or terminated a Rule 10b5-1 trading arrangement or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2026.